Drug makers still sweating over 2013 business plan

A majority of Korean pharmaceutical companies are still struggling to finalize their business plans for the new year, industry sources said.

Economic uncertainty has led many companies to say they have no plans to jump into a new business next year, raising fears that their profits will continue to fall in the domestic market after comprehensive price cuts of drugs by the government in April...